On June 2, 2017, Avadel Pharmaceuticals plc (the “Company”)
furnished to the holders of its ordinary shares and American
Depositary Shares (collectively, “Holders”) a copy of the
Company’s Irish statutory financial statements and related
reports of the Company for the period beginning December 1,
2015 (date of incorporation) through December 31, 2016, which
have been prepared to Irish law (collectively, the “Irish
Statutory Accounts”). The Irish Statutory Accounts will be
presented by management at the Company’s Annual General
Meeting of shareholders which is scheduled to be held at
12:00 Noon (Irish Standard Time) on Wednesday, June 28, 2017
at the offices of Arthur Cox, Ten Earlsfort Terrace, Dublin
2, D02 T380, Ireland. The Irish Statutory Accounts were sent
to Holders in advance of the Company’s Annual General
Meeting, as required by Irish law, under cover of a letter, a
copy of which is furnished as Exhibit 99.1 to this current
report on Form 8-K and is incorporated herein by reference.

The Irish Statutory Accounts are based on the Company’s
financial statements which were prepared in accordance with
U.S. generally accepted accounting principles (“US GAAP”)
and which were filed as part of the Company’s Annual Report
on Form 10-K; provided, however, that the Irish
Statutory Accounts include disclosures and presentation
formats required by the Republic of Ireland’s Companies Act
2014 and which may not be required by US GAAP. A copy of the
Irish Statutory Accounts is furnished as Exhibit 99.2 to this
current report on Form 8-K and is incorporated herein by
reference.

The Irish Statutory Accounts will also be available on the
Company’s website.

The information in this Item 7.01, including Exhibits 99.1
and 99.2, is being furnished and shall not be deemed
“filed” for purposes of Section 18 of the Securities
Exchange Act of 1934 (the “Exchange Act”), or as otherwise
subject to liability of that section, nor shall such
information be deemed to be incorporated by reference into
any registration statement or other document filed under the
Securities Act of 1933 or the Exchange Act.